OncoPredict Solutions leverages cutting-edge artificial intelligence to forecast patient-specific responses, ensuring oncologists make data-driven decisions tailored to each individual.
OncoPredict Solutions is a cutting-edge platform empowering oncologists with personalized cancer treatment insights. By analyzing clinical, genomic, and real-world data, our AI models predict patient-specific responses to therapies, minimizing trial-and-error approaches. Our mission is to transform cancer care by enabling precision oncology, improving patient outcomes, and delivering targeted treatments more efficiently.
Precision Oncology is a personalized approach to cancer care that uses advanced technologies and data-driven insights to identify therapies that are most likely to work for each individual patient. Instead of relying on standard treatments, precision oncology tailors therapy based on a patient’s unique genetic makeup, tumor characteristics, and real-world data.
OncoPredict Solutions analyzes clinical, genomic, and molecular data to uncover the specific genetic mutations driving a patient’s cancer. By understanding these mutations, oncologists can select targeted therapies designed to block the cancer’s growth pathways — improving effectiveness and minimizing harmful side effects.
"Empowering precision oncology—every step of the care pathway." — Veronica Mugendi; CEO OncoPredict Solutions
We aggregate and normalize your institution’s clinical records, tumor genomics, radiology, and pathology images into a single secure lakehouse—eliminating data silos and giving oncologists a 360‑degree patient view ready for AI analysis.
Our ensemble of deep‑learning models simulates how an individual patient will respond to hundreds of approved and investigational therapies. OncoPredict flags the most promising regimens and de‑prioritizes those with low predicted efficacy—cutting guess‑and‑check medicine out of the workflow.
Our NLP engine parses global trial registries in real‑time and cross‑matches inclusion/exclusion criteria against your patient population. Cohort‑level analytics help investigators forecast enrollment velocity, streamline IRB submissions, and accelerate first‑patient‑in.
OncoPredict continuously ingests fresh labs, imaging, and patient‑reported outcomes. ML‑powered drift detection spots emerging resistance or adverse events weeks earlier than conventional methods and notifies the care team through EHR‑integrated alerts.
Dynamic dashboards quantify improvements in progression‑free survival, cost‑per‑QALY, and guideline adherence across service lines. Exportable reports support value‑based contracting, payer negotiations, and publication‑ready real‑world‑evidence studies.
This pie chart represents the statistical findings from OncoPredict AI's performance in improving cancer treatment processes:
These findings reflect the power of OncoPredict AI in supporting precision oncology and improving patient outcomes.
Understand genetic and molecular testing and how it guides your personalized treatment.
Connect with other patients, share experiences, and gain emotional support through trusted groups.
Explore active clinical trials globally and learn about new treatment possibilities.
Access expert mental health resources to support your emotional well-being throughout treatment.